MG

Monika Gupta

Active Director Director DIN 06416918
DIN 06416918 First appointment Dec 2012 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2012
Shareholding value •••• Premium profile

About Monika Gupta

Data last updated:

Monika Gupta is a Director at Aspiris Pharmaceuticals Private Limited (since 2012). The company operates in Chemicals. Aspiris Pharmaceuticals Private Limited reported revenue of ₹14.4 Lakh (FY 2024).

DIN 06416918
Primary Designation Director
Industry Chemicals
First Appointment 14 Dec 2012
Oldest Company Age 13 yrs
Largest company Aspiris Pharmaceuticals Private Limited · ₹14.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Dec 20122012₹14.4 Lakh (FY 2024)Active

Board colleagues of Monika Gupta

Directorship timeline

Open interactive timeline →
Aspiris Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Monika Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Monika Gupta

Monika Gupta currently holds 1 directorship: Aspiris Pharmaceuticals Private Limited (Director, since 14 Dec 2012, revenue ₹14.4 Lakh (FY 2024)).

Monika Gupta was first appointed on 14 Dec 2012 as Director at Aspiris Pharmaceuticals Private Limited.

The current boards of Monika Gupta's companies include Gagan Deep Jha (Aspiris Pharmaceuticals Private Limited), Vaibhav Gupta (Aspiris Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available